Companies are throwing away millions because they are not taking advantage of the lucrative tax relief available on research and development (R&D), says Mark Tighe, CEO of tax relief specialists Catax: “What many small firms don’t realise is that you don’t have to be an international pharmaceutical company to take advantage.
To read full article click here